Anti-Omalizumab Mouse Monoclonal Antibody [clone: 10G3]

Supplier: Genscript
GenScript®
A02095-40
77007-620EA 153.9 USD
77007-620
Anti-Omalizumab Mouse Monoclonal Antibody [clone: 10G3]
Antibodies
Omalizumab with trade name Xolair, is an FDA-approved drug for the treatment of moderate to severe persistent asthma in adults and adolescents (12 years of age and above). It is a recombinant humanized monoclonal antibody. It selectively binds to human immunoglobulin E (IgE). Omalizumab inhibits the binding of IgE to the high-affinity IgE receptor (FcεRI) on the surface of mast cells and basophils. Anti-Omalizumab Antibody (10G3), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Omalizumab.

  • High specificity
  • High affinity
  • High stability

GenScript has developed a broad range of off-the-shelf anti-idiotype antibodies against blockbuster drugs to help accelerate your research of biosimilars.

Type:
Antigen: Omalizumab
Clonality: Monoclonal
Clone: 10G3
Conjugation:
Epitope:
Host: Mouse
Isotype: IgG1 kappa
Reactivity:
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR